New Accessible Transportation for Persons with Disabilities Regulations now in force
Starting today, persons with disabilities have new protections under the Canadian Transportation Agency’s (CTA) Accessible Transportation for Persons with Disabilities Regulations (ATPDR).
The ATPDR require transportation service providers to:
- ensure that aircraft, trains, ferries, buses and terminals (such as airports) are accessible by complying with specific technical requirements;
- meet communication needs of travellers with disabilities;
- provide accessible services; and
- make border and security screening more accessible.
The ATPDR establish new, legally binding and enforceable requirements for accessible transportation, building on two older regulations and six codes, as well as best practices in Canada and around the world.
More information on the requirements is available on our website. The CTA has also developed extensive guidance materials, available in accessible formats. This guidance explains, in plain language, the requirements of the ATPDR. It also takes into account questions raised by stakeholders during consultations.
The final regulations reflect input received by the CTA from persons with disabilities and industry, including members of the CTA's Accessibility Advisory Committee, as well as the general public during several rounds of consultation between 2016 and 2019.
The ATPDR are part of the CTA's Regulatory Modernization Initiative (RMI), a review of all the regulations and guidelines the CTAadministers.
"Persons with disabilities have a fundamental right to travel that is as free of barriers as possible. The groundbreaking Accessible Transportation for Persons with Disabilities Regulations will help protect this right – and advance our vision of making Canada's national transportation system the most accessible in the world. The CTA will continue working with disability rights organizations and industry to translate this goal into reality."
Scott Streiner, Chair and CEO of the Canadian Transportation Agency
Most provisions of the ATPDR – over 200 – are now in force. Due to the severe disruptions to the transportation sector caused by COVID-19, a handful of more technically or operationally complex provisions are being delayed to January 1, 2021. Finally, as planned, some more complex provisions are being phased-in over two years until 2022.
Another regulatory initiative related to accessible transportation is also underway. It would require transportation service providers to develop accessibility plans and reports based on the Accessible Canada Act (ACA). As well, further discussions will take place in the fall before developing requirements pertaining to small transportation service providers.
NCT04465201Not yet recruitingConditions: Cardiac Output
NCT04465214Not yet recruitingConditions: Neoplasms; Solid Tumors; Prostate Cancer; Lung Cancer; Colon Cancer
NCT04465227Not yet recruitingSafety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)Conditions: Hypoparathyroidism
NCT04465240Not yet recruitingConditions: Residential Characteristics; Emotions; Stress, Psychological; Stress, Physiological
NCT04465253RecruitingRemotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related LymphedemaConditions: Breast Carcinoma; Lymphedema
NCT04465279CompletedConditions: Refractive Errors
NCT04465292Not yet recruitingConditions: Pemphigoid, Bullous
NCT04465305RecruitingA Randomized Controlled Study on the Treatment of Sacral Canal Cysts With Sacral Canal ReinforcementConditions: Tarlov Cysts
NCT04465318Not yet recruitingConditions: COPD
Featured Contract Research Organizations
We are an international company based in Parma, with 80 years of experience and a strong focus on research, development, production and the commercial...
Accutest is a global independent and internationally accredited Contract Research Organisation (“CRO”) founded in 1998. We are offering services to cu...
NCGS INCORPORATED, FOUNDED IN 1984, IS INTERNATIONAL, FULL-SERVICE CRO THAT SPECIALIZES IN CONDUCTING AND MANAGING CLINICAL TRIALS
Pharmaron is a premier R&D service company supporting the life science industry. Founded in 2004, Pharmaron has invested in its people and facilities...